Advanced Search


Study ID Status Title Patient Level Data
116829 Completed Clinical and cost impact of complete and incomplete rotavirus vaccination
116830 Completed Clinical and cost impact of complete and incomplete Rotarix vaccination
116831 Completed A retrospective database analysis of clinical outcomes in BPH patients treated with 5‑alpha reductase inhibitors in the Netherlands.
116842 Completed Estimation of COPD health utilities in Spain
116843 Completed Cost of COPD exacerbations in Spain
116844 Completed Meta-Analysis Results Report for DB2116844: Meta-analysis of DB2113360 and DB2113374: an Integrated Review of Transition Dyspnoea Index data for Umeclidinium/Vilanterol, Umeclidinium, Vilanterol and Tiotropium over 24 Weeks in Subjects with COPD
116850 Completed Bioequivalence study between two medications for administration of Oral Gabapentin in 300 mg capsules in healthy volunteers
116853 Completed A Phase III, 24 Week, Randomized, Double Blind, Double Dummy, Parallel Group Study (with an Extension to 52 Weeks in a Subset of Subjects) Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination FF/UMEC/VI Administered Once Daily in the Morning via a Dry Powder Inhaler with Budesonide/Formoterol 400mcg/12mcg Administered Twice-Daily via a Reservoir Inhaler in Subjects with Chronic Obstructive Pulmonary Disease Study Listed on
116859 Completed Flolan® Article 81, a retrospective observational study of the cohort of pulmonary arterial hypertension patients treated by Expert Centres in Belgium with Flolan® (epoprostenol).Flolan® is a registered trademark of the GlaxoSmithKline group of companies.
116861 Completed Safety and tolerability of GSK 1557484A vaccine in adults at occupational risk for influenza A (H5N1) exposure
116863 Completed A Randomized, Double-Blind, Parallel Group, Multicenter Study of Fluticasone Furoate/Vilanterol 200/25 mcg Inhalation Powder, Fluticasone Furoate/Vilanterol 100/25 mcg Inhalation Powder, and Fluticasone Furoate 100 mcg Inhalation Powder in the Treatment of Persistent Asthma in Adults and Adolescents Study Listed on
116878 Terminated Study PTG116878, a Dose-Optimization Study of Ezogabine/Retigabine Immediate Release Tablets versus Placebo in the Adjunctive Treatment of Subjects with Partial-Onset Seizures Study Listed on
116882 Not yet recruiting Anti-inflammatory effects of salmeterol, fluticasone propionate and the combination in epithelial cells from Japanese COPD patients
116883 Completed Study of chronic obstructive pulmonary disease (COPD) prevalence in Japanese subjects with smoking history who are aged 40 years or older and consulting periodically for cardiovascular disease
116885 Completed A Japanese open-label Phase I/II study to assess the safety, tolerability, pharmacokinetics and efficacy of GSK2118436 and GSK1120212 combination therapy in subjects with BRAF V600E/K mutation positive advanced solid tumors (Phase I part) and BRAF V600E/K mutation positive cutaneous melanoma (Phase II part).
116886 Completed Observer-blind study to evaluate immunogenicity and safety of GSK Biologicals’ Herpes Zoster subunit (HZ/su) vaccine GSK1437173A in adults 18 years of age or older with renal transplant
116887 Completed Immunogenicity and safety study of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A when co-administered with Boostrix® in adults aged 50 years and older
116889 Completed Immunogenicity and safety study of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A when co-administered with Pneumovax 23™ in adults aged 50 years and older
116891 Completed A Randomized, Open Label, Parallel-Group Study to Estimate Bioavailability and to Assess the Pharmacokinetic Profile, Safety and Tolerability of GSK933776 Administered by Subcutaneous or Intramuscular Injection Relative to Intravenous Administration to Healthy Volunteers Study Listed on
116892 Relinquished Immunogenicity and safety study of 1 and 2 doses of GSK Biologicals’ meningococcal vaccine GSK134612 in toddlers, persistence up to 5 years after vaccination and co-administration with Pfizer's pneumococcal vaccine Prevenar 13™
116895 Completed Healthcare seeking behaviour of primary caregivers for acute otitis media in children aged 6 months to less than 30 months in Panama
116897 Completed A Single-Dose, Randomised, Open-Label, Two-Period Crossover Study to Determine the Bioequivalence of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in the Fasted State in Healthy Adult Male Subjects Study Listed on
116898 Completed A Phase I, Open Label, Randomized, Four-Period Crossover Study to Evaluate the Effects of Calcium Carbonate 1200 mg and Ferrous Fumarate 324 mg on Pharmacokinetics of Dolutegravir 50 mg in Healthy Adult Subjects
116911 Completed Indirect Treatment Comparison to Inform the Evaluation of the Cost-Effectiveness of Lapatinib plus Letrozole for First-Line Treatment of Post-Menopausal Women with Hormone Receptor Positive and HER-2 Positive Metastatic Breast Cancer from Canadian Societal and Healthcare System Perspectives
116914 Completed Administrative Database Study on the Impact of Adherence to Drug Therapy in Asthma Patients Treated with ADVAIR or Fluticasone Propionate in Quebec



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.